ATSDR
Environmental Medicine | CSEM | GREM | Continuing Education | Patient Education | PEHT | Community
Section Contents
Learning Objectives
Introduction
Key Points
Progress Check
 
Case Contents
Table of Contents
Cover Page
How to Use the Course
Initial Check
Mass Casualty Events
Cholinesterase Inhibitors
Pathological Conditions
Cholinergic Toxidrome
Nicotinic Receptors
Muscarinic Receptors
Nicotinic/Muscarinic Mixture
Signs and Symptoms
Differential Diagnosis
Pediatric Cases
Exposure History
RBC & Serum Tests
Inhibitors & Byproducts
Management Strategies
Secondary Exposure
Supportive Care
First-Line Medications
Medications: Atropine
Medications: Pralidoxime
Medications: Diazepam
Antidote Stocking
Deprecated Treatments
Medico-Legal Issues
Intermediate Syndrome
Delayed Neuropathy
Chronic Neurotoxicity
Other Issues
Posttest
Literature Cited
 
Related Documents
MMG: Nerve Agents
ToxFAQs™: Nerve Agents
 
Environmental Medicine
CSEM
GREM
PEHT
Continuing Education
Online Registration
Patient Education
Community Education
 
ATSDR Resources
ATSDR en Español
Case Studies (CSEM)
Exposure Pathways
HazDat Database
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA

Agency for Toxic Substances and Disease Registry 
Case Studies in Environmental Medicine (CSEM) 

Cholinesterase Inhibitors
Including Insecticides and Chemical Warfare Nerve Agents
Part 4: The Cholinergic Toxidrome
Section 6: Effects on Routine Laboratory Tests

Learning Objectives

Upon completion of this portion of the case study, the learner should be able to:

  • Describe what routine laboratory tests can be altered by acute cholinesterase inhibitor toxicity.

Introduction

Routine laboratory test results are usually normal in patients with cholinesterase inhibitor toxicity. However, a few notable exceptions may confound the diagnosis. Examples are listed in the table below. (Schenker, Louie et al. 1998; Tareg et al. 2001; Wiener and Hoffman 2004)

Laboratory Test Results That May Occur in Cholinesterase Inhibitor Toxicity Presumed Cause

EKG

Note: In a series of 105 cases, Hayes et al. found that --- with the exception of rate changes --- EKG abnormalities occurred only 5% of the time. (Hayes, van der Westhuizen et al. 1978)

  • Tachycardia or bradycardia (Leikin, Thomas et al. 2002)
  • A-V block (Suzuki, Kohno et al. 1997)
  • Prolonged Q-T (Clark 2002)
  • Peaked T-waves (Hayes, van der Westhuizen et al. 1978)
  • Torsades de pointes (Leikin, Thomas et al. 2002)

 

Ketoacidosis

Present (Schenker, Louie et al. 1998)

n/a

Serum amylase

Elevated (Tareg et al. 2001; Wiener and Hoffman 2004)

Injury to pancreas from parasympathetic over­stimulation and hypersecretion (Tareg et al. 2001)

Serum creatine kinase (CK)

Elevated (Okumura, Takasu et al. 1996; Wiener and Hoffman 2004)

Fasciculations, seizures

Serum glucose

Elevated (Hayes, Wise et al. 1980; Schenker, Louie et al. 1998; Tareg et al. 2001)

Nicotinic effect on the adrenal medulla with catecholamine release (Tareg et al. 2001)

Serum lipids and triglycerides

Decreased (Wiener and Hoffman 2004)

n/a

Serum potassium

Decreased (Suzuki, Kohno et al. 1997; Tareg et al. 2001; Wiener and Hoffman 2004)

Increased

Nicotinic effect on the adrenal medulla with catecholamine release (Tareg et al. 2001)

Effect of muscular activity during seizures

Urine glucose

Elevated (Hayes, Wise et al. 1980; Schenker, Louie et al. 1998; Tareg et al. 2001)

Nicotinic effect on the adrenal medulla with catecholamine release (Tareg et al. 2001)

Urine proteins

Elevated (Hayes, Wise et al. 1980; Schenker, Louie et al. 1998; Tareg et al. 2001)

n/a (Tareg et al. 2001)

White blood cell count

Elevated with a left shift (Hayes, Wise et al. 1980; Okumura, Takasu et al. 1996; Schenker, Louie et al. 1998; Tareg et al. 2001)

Nicotinic effect on the adrenal medulla with catecholamine release (Tareg et al. 2001)

n/a = not addressed in the reference.

Key Points

  • A number of routine laboratory tests can be altered due to the cholinergic toxidrome of cholinesterase toxicity.
  • These can lead to misdiagnosis.

Progress Check

22. Cholinesterase toxicity has been known to cause abnormally high levels of which of the following laboratory tests. (Choose ALL correct answers)

A. Serum glucose.
B. White blood cell count.
C. Serum amylase.
D. CPK.
E. None of the above.

Answer:

To review relevant content, see Introduction in this section.

Previous Section

Next Section

Revised 2007-10-16.